{
    "2021-03-25": [
        [
            {
                "time": "",
                "original_text": "重慶智飛生物重組新冠疫苗獲批供緊急使用，預計今年可產3~5億劑",
                "features": {
                    "keywords": [
                        "智飛生物",
                        "重組新冠疫苗",
                        "緊急使用",
                        "3~5億劑"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫療",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飛生物、康泰生物急速跳水，疫苗板塊回落",
                "features": {
                    "keywords": [
                        "智飛生物",
                        "康泰生物",
                        "疫苗板塊",
                        "跳水",
                        "回落"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫療",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "五糧液、中免、美的、寧德時代、智飛生物、愛爾眼科、海爾均跌超2%",
                "features": {
                    "keywords": [
                        "五糧液",
                        "中免",
                        "美的",
                        "寧德時代",
                        "智飛生物",
                        "愛爾眼科",
                        "海爾",
                        "跌超2%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消費",
                        "科技",
                        "醫療"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2021年1-2月疫苗批簽發數據跟蹤報告：二類疫苗快速增長 熱門大品種表現亮眼",
                "features": {
                    "keywords": [
                        "2021年1-2月",
                        "疫苗批簽發",
                        "二類疫苗",
                        "快速增長",
                        "熱門大品種"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "醫療",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}